Tenders/Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service

Open🇬🇧United KingdomServices

Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service

NHS England

Published: Jun 4, 2026

Updated: Jun 5, 2026

Source: uk_fts

About This Opportunity

This is a services contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in United Kingdom, Europe, this opportunity is open to firms and consortiums, with an estimated budget of GBP 26.1 million. Proposals must be submitted before July 8, 2026.

Published through UK FTS - Find a Tender Service, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Onasemnogene abeparvovec intravenous (Zolgensma®) is a one-time, in vivo gene replacement therapy, for use in babies aged 12 months and under, that utilises an adeno-associated virus serotype 9 (AAV9) vector, modified to contain a functional copy of the human SMN1 gene. It is administered intravenously, allowing the vector to deliver the gene into motor neurones and peripheral tissues, enabling the sustained expression of survival motor neuron (SMN) protein, which is deficient or mutated in individuals with SMA. Onasemnogene abeparvovec intrathecal (OAV101 IT) is a one-time in vivo gene replacement therapy for patients with SMA, proposed to treat individuals with SMA aged 2 years and over. This intrathecal injection will be used to treat a distinct cohort of SMA patients to Zolgensma. It will be assessed via NICE’s technology appraisal programme, with an expected final guidance publication date in late 2026. Lot 1: Zolgensma only (if no positive NICE recommendation for OAV101 IT) Lot 2: Positive recommendation for OAV101 IT for paediatric patients (in combination with Lot 1 for Zolgensma) Lot 3: Positive NICE recommendation for OAV101 IT for adult patients (either standalone or in combination with Lots 1 and 2)

Data provenance

This notice is sourced from UK FTS - Find a Tender Service and was originally published on June 4, 2026. Last refreshed today. Reference: 053026-2026. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About NHS England

NHS England has issued 645 procurement notices on BidsFactory, including 37 currently open and 522 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and Education & Training. All notices are published for United Kingdom. Notices are distributed via UK FTS - Find a Tender Service and UK Contracts Finder. Most recent publication: June 4, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit UK FTS - Find a Tender Service to access the full notice, required documents, and submission instructions. Quote reference 053026-2026 when communicating with the contracting authority.

When does this tender close?

The submission deadline is July 8, 2026. You have 34 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by NHS England in United Kingdom. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is £26,136,000 - £26,136,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in United Kingdom. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.